Amsterdam-based skin cancer screening app SkinVision has raised $7.6 million in new funding from existing investors Leo Pharma and PHS Fund, with additional contributions from undisclosed new backers described by the company as "high net worth impact investors."
This is the second major funding raise for the company, which launched in 2012 under the name Skin Scan, after a $3.4 million round in...
